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inclusion criteria for the study. Of the 121 neonates,
89 (73.6%) presented with various risk factors for sep-
sis prior to or at the time of diagnosis and maternal
risk factor was the highest reported (37.2%). Culture
and sensitivity was negative or not conducted in about
74% of the patients. Among those with positive culture
tests, methicillin-resistant staphylococcus aureus (MRSA)
and methicillin-resistant staphylococcus epidermidis (MRSE)
constituted the most prevalent microbial isolates (32.3%).
All the patients received some form of empiric antibiotic
therapy, but only 26 (21.5%) received culture-directed ther-
apy. Crystalline penicillin G plus gentamicin regimen was the
most commonly prescribed empiric therapy (69.4%). There
was about 9 folds difference between the acquisition costs
of the most widely and the second most widely used regi-
men (RM 29.32 per patient vs. RM 264.74 per patient). Four
patients (3.3%) died during hospitalization in the NICU and
107 (88.4%) were discharged clinically well.
Conclusion: This study has an important implication in
guiding policy for developing comprehensive, evidence-
based practice guidelines, adherence to which may lead
to improved rational antibiotics use, costs reduction and
improvement of overall care of patients with neonatal sep-
sis.
doi:10.1016/j.ijid.2008.05.211
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Introduction: Hepatitis E virus (HEV) is an enterically
transmitted acute viral hepatitis with the highest incidence
in Asia, Africa, Middle East and Central America. There are
few published data about the epidemiology of the infection
in Iran. So, this study was carried on to evaluate anti-HEV
seroprevalence in Isfahan Province-Iran.
Methods: In a cross sectional study, 816 subjects over 6
years rural from urban and rural areas of Isfahan Province
in 2005 using multi stage cluster sampling method were
selected. Demographic dada and blood samples were col-
lected and anti-HEV antibodies were measured by ELISA
method. Chi-square test was used for statistical analysis and
P < 0.05 was considered signiﬁcant.
Results: The subjects of this study included 428 female
(52.5%) and 388 male (47.5%). The overall anti-HEV
seroprevalence rate was 3.8%. There was no signiﬁcant dif-
ference in HEV seropositivity between the subjects grouped
according to sex (4.2% in females and 3.4% in males,
P = o.78), household number (P = 0.095) and living area (2.7%
in rural and 4.1% in urban areas, P = 0.09). HEV seropreva-
lence increased with age from 0.9% in children 6-9 years to
8% in persons over 50 years old without statistical differ-
ences in them (P = 0.08).
There were statistical differences between HEV seroposi-
tivity in regions of Isfahan Province which the most was seen
in Khomeini Shahr (13.3%) (P < 0.001).
Conclusion: HEV seroprevalence in Isfahan Province is
lower than previous reports in other parts of Iran and Middle
East area. More studies in other parts of Iran are needed to
obtain a prevalence map for creating prevention strategies.
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Background: This study is aimed to evaluate the sero-
prevalence of anti-parvovirus B19 IgG in communities,
pregnant women, and health care workers (HCWs) in Tai-
wan, and to ﬁnd out the possible risk factors associated with
parvovirus B 19 infections in HCWs.
Methods: Totally 763 serum samples were tested for anti-
parvovirus B19 IgG by enzyme immunoassay. Among them,
467 represented the general population, aged 1—69 years of
age, female to male ratio of 1.0, collected from the commu-
nity during the years of 2006—2007 and 2004; other 241 were
from pregnant women, aged 15—51 years, randomly sampled
in a national-wide screening program of rubella in pregnancy
in 2000; the other 55 were from the HCWs, aged 25—57
years, who received and completed the questionnaires at
the time of blood sampling.
Results: The overall seroprevalence of parvovirus B19
infection in the community and among pregnant women
and HCWs were 34.0%, 27.8%, and 23.6% respectively. In
the community group, the seroprevalence increased with
age (p < 0.0001). The seropositivity remained stable (20-30%)
in subjects aged 20 to 40 years in the community group.
Then, it rose up to 60% after the middle age (46 years and
beyond). No difference was observed between the seroposi-
tivities of pregnant women and the community women with
the same age (OR = 1.5, 95% CI: 0.9—2.5). Among HCWs,
those with longer clinical working experience were associ-
ated with higher seroprevalence of parvovirus B19 infection
(p = 0.04). However, the association was not signiﬁcant after
adjusted with age (p = 0.07).
Conclusions: The seroprevalence of Parvovirus B19 infec-
tion in Taiwan increased with age, especially for people over
45 years but was still lower than those in western countries.
For women with childbearing ages, the seropositivity was
low and not different from the women with matched age in
the community. HCWs did not have a higher seroprevalence
of Parvovirus B19.
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